Keywords: AstraZeneca, Share buybacks. Sanofi, Exec appointment, Octapharma, Research facility

News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma

Article | 02 October 2012

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) saw its shares dip 1.8% to £29.02 in early afternoon trading yesterday (down 1% at £29.25 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in